No Prescription |
 |
 | ||
|
Aldactazide Generic Spironolactone Hydrochlorothiazide |
|
| ||
No Prescription » Prescription Drugs 1 » Aldactazide Generic Spironolactone Hydrochlorothiazide Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: This product is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes heart attacks and kidney problems. This product is also used to treat swelling/water retention (edema) which can result from conditions such as heart failure severe liver disease or severe kidney disease. Reducing swelling/water retention can help to improve symptoms such as trouble breathing.This product contains two medications spironolactone and hydrochlorothiazide. Both are water pills (diuretics) that work by increasing the amount of urine that you make. This causes your body to get rid of extra salt and water which is thought to help relax the blood vessels so that blood can flow more easily. Spironolactone also blocks the activity of a certain natural substance made by your body (aldosterone) that may contribute to swelling/fluid retention in certain conditions. Buy Aldactazide Generic Spironolactone Hydrochlorothiazide and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About Aldactazide Generic Spironolactone Hydrochlorothiazide: Product Type: Prescription Drugs 1 Aldactazide ( Generic Spironolactone & Hydrochlorothiazide ) Aldactazide (Generic Spironolactone & Hydrochlorothiazide) Generic Spironolactone & Hydrochlorothiazide 25mg 90 Tablets 25mg 180 Tablets 25mg 30 Tablets 50mg 30 Tablets 50mg 90 Tablets 50mg 180 Tablets Generic Spironolactone & Hydrochlorothiazide Aldactazide
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
